Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

A new study has somewhat redeemed the tau protein, which up to now has been associated with the development of Alzheimer’s disease. Turns out, the protein has a ‘good guy’ role, helping to ...

Some people know their passion at an early age, it’s not a puzzle for them to tap into their calling, however, this is not a ...

The BBC's Pumza Fihlani went to investigate. When I meet 17-year-old Kholofelo Moholola, she is holding her two six-month-old babies, one in each arm, trying to comfort them. It is feeding time ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Voyager Therapeutics, Inc. (NASDAQ:VYGR) is in the process of developing its anti-Tau antibody VY7523 for the treatment of patients with Alzheimer's Disease [AD] in a phase 1a single-ascending ...

Kaizer Chiefs-linked Percy Tau continues to be mentioned along side an Al Ahly exit ahead of next season. Tau still has more ...

IGC-1C Targets Tau Protein and GLP-1 Receptor, Offering a Multi-Pathway Approach to Neurodegenerative and Metabolic Disease Treatment POTOMAC, Md., August 22, 2024--(BUSINESS WIRE)--IGC Pharma ...

Having a stable economy for that period ‘would do wonders in moving the dialog forward’ and even help in the short term with stabilisation,’ Victor Steenbergen said.